Skip to main navigation Skip to main content Skip to page footer
Biohealthyour Full Service experienceFrom concept to market readiness – with Biohealth, you have a trusted partner by your side, seamlessly combining quality and efficiency in the dietary supplement industry. Leverage our expertise to turn your vision into reality!Start your BHI Journey

Your contract manufacturer for food supplements

Passion for over 20 years

Health food is anything but a short-term trend. More and more people today are living health-conscious lives, exercising and want to optimize or supplement their diet - and thus form an attractive target group for specially developed foods. As an experienced expert in the field of CDMO (Contract Development & Manufacturing Organization), we at Biohealth offer you the best conditions to be successful in this market with your own products.
Biohealth has been known for over 20 years as a contract manufacturer for nutritional supplements and health food solutions made in Germany. We draw on extensive experience in the food industry and use this valuable know-how for specialized products in a wide variety of dosage forms. As a source of ideas and an inspiring partner, we want to support you and your brand on the road to success. Your advantage: As a contract manufacturer, Biohealth does not manage its own brands, we work for your success.

To our full service

The path to becoming an international contract manufacturer

Biohealth International was founded in 2003 by Rudolf Gebhardt. From the beginnings of production with just one production assistant and dedicated family members, the company has developed into a dynamically growing company with around 220 permanent employees at its site in Münchberg, Bavaria.

Biohealth International has been part of a strategic joint venture with Uelzena eG since 2020. Uelzena eG, headquartered in Uelzen, Lower Saxony, and with four subsidiaries in Germany, is one of the leading providers and innovative problem solvers in food processing and milk refinement. The partnership with Uelzena opens up prospects for sustainable growth and innovative product solutions - with the clear aim of further expanding Biohealth as a leading provider in the private label health market. By mid-2025, Uelzena eG will increase its strategic stake in Biohealth International to 80%, demonstrating the confidence of all shareholders in Biohealth's strategy and potential.

Biohealth International has continuously expanded its production capacities due to its rapidly growing customer base. The site in Münchberg currently covers a total of over 20,000 square meters.

More about our production

In 2024, BHI Biohealth International has launched another comprehensive investment programme of around EUR 10 million in buildings, facilities and the digitalization of production at the Münchberg site. From mid-2025, we will also be able to cover around 70% of our annual electricity consumption with sustainable energy. To this end, we are investing in a photovoltaic system. With this measure, BHI is assuming its responsibility for a sustainable and liveable environment.

More about our investments

"With this investment program, Biohealth is supporting the growth and excellence of its customers. Our goal is to strengthen our customers' brands through service, quality and innovation - to achieve this, we are investing in buildings, machinery and digitalization as well as in sustainable production."

#unserCEO